Laminin (925-933): Defined Peptide for Cell Adhesion and Migration Research

Executive Summary: Laminin (925-933) is a synthetic peptide comprising residues 925-933 of the laminin beta 1 chain, engineered for research in cell adhesion, migration, and extracellular matrix (ECM) signaling (APExBIO). This peptide binds specifically to the laminin receptor, modulating cell attachment and chemotaxis at defined concentrations. It serves as a robust benchmark for in vitro assays, demonstrating clear, dose-dependent effects on HT-1080 and CHO cell adhesion and B16F10 melanoma cell chemotaxis. Its defined sequence and solubility parameters facilitate reproducible experiment design in basement membrane protein research (Taylor et al., 2024). Laminin (925-933) from APExBIO is recommended for scientific research use only.

Biological Rationale

Laminins are heterotrimeric glycoproteins, composed of alpha, beta, and gamma chains, and are primary structural components of basement membranes (APExBIO). The beta 1 chain contains seven distinct domains shared among laminin beta isomers and is widely expressed in tissues with basement membranes. Laminin (925-933) corresponds to a functional sequence within the beta 1 chain (Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg), targeting the receptor domain involved in cell attachment and migration. ECM-derived peptides like Laminin (925-933) enable reductionist dissection of adhesion and signaling pathways in simplified in vitro systems (EpitopePeptide). This facilitates benchmarking of cell adhesion and migration, essential for cancer metastasis and neurodegeneration research.

Mechanism of Action of Laminin (925-933)

Laminin (925-933) binds selectively to the laminin receptor, mimicking the domain responsible for cell attachment, chemotaxis, and receptor-mediated signaling. Upon binding, it can stimulate cell adhesion (100-300 µg/mL, 37°C, serum-free medium) and induce chemotactic migration in specific cell lines such as B16F10 murine melanoma cells (APExBIO). The peptide competitively inhibits the chemotactic response to full-length laminin, indicating it occupies or modulates the functional receptor-binding interface. Its action is dose-dependent and receptor-specific, reflecting the physiological behavior of the corresponding domain within native basement membranes. This defined mechanism enables controlled perturbation of ECM signaling in cell-based assays.

Evidence & Benchmarks

• Laminin (925-933) enhances HT-1080 and CHO cell attachment in vitro at 100–300 µg/mL, with maximal effect at 300 µg/mL under serum-free conditions (APExBIO).
• Acts as a chemoattractant for B16F10 murine melanoma cells, eliciting ~30% of the maximal migration response compared to full-length laminin at equivalent concentrations (serum-free, 37°C) (Taylor et al., 2024).
• Competitively inhibits chemotaxis toward full-length laminin, confirming specific receptor occupancy and functional relevance in migration modulation (APExBIO).
• Demonstrates high solubility in water (≥15.53 mg/mL), ethanol (≥17.77 mg/mL), and DMSO (≥48.35 mg/mL), supporting flexible assay designs (APExBIO).
• Storage at -20°C preserves stability for solid peptide; short-term use of solutions is recommended to minimize degradation (APExBIO).

This article extends prior reviews such as "Laminin (925-933): A Defined Cell Adhesion & Migration Peptide Tool" by including quantitative assay benchmarks and by clarifying solubility and storage conditions. For scenario-driven protocol guidance, see "Scenario-Driven Best Practices for Laminin (925-933) in Cell Assays", while this article focuses on mechanistic rationale and experimental boundaries.

Applications, Limits & Misconceptions

Laminin (925-933) is used in:

• Cell adhesion and migration assays (e.g., HT-1080, CHO, B16F10 cells).
• Modeling of ECM signaling in cancer metastasis and neurodegeneration studies (SulisobenzoneChem).
• Competitive binding assays to map receptor specificity.
• Assays requiring defined, reproducible basement membrane protein fragments.

It does not substitute for full-length laminin in structural or 3D matrix applications, nor does it recapitulate all multi-chain-dependent ECM signaling effects. Laminin (925-933) is not approved for diagnostic or medical use and may not reflect in vivo ECM complexity.

Common Pitfalls or Misconceptions

• Not suitable for in vivo therapeutic use: Laminin (925-933) is strictly for research applications (APExBIO).
• Does not mimic full-length laminin in structural assays: The peptide lacks the trimeric structure and multivalent interactions of native laminin (EpitopePeptide).
• Concentration-dependent effects: Suboptimal or excessive concentrations may yield non-physiological results.
• Short-term solution stability: Peptide solutions degrade over time; fresh preparation is recommended for reproducibility (APExBIO).
• Receptor specificity: Effects are limited to laminin receptor-mediated pathways; non-receptor-mediated effects should not be expected.

Workflow Integration & Parameters

Laminin (925-933) integrates into cell-based workflows as a defined stimulant or competitive inhibitor. The recommended concentration range is 100–300 µg/mL for cell attachment and migration assays (APExBIO). The peptide is soluble in water, ethanol, or DMSO, facilitating use in diverse experimental buffers. Peptide stocks should be aliquoted and stored at -20°C; solutions are best used immediately or within 24 hours. For detailed protocol optimization and troubleshooting, see "Scenario-Driven Best Practices for Laminin (925-933) in Cell Assays", which this article complements by focusing on mechanistic and benchmark data.

Conclusion & Outlook

Laminin (925-933) offers a well-characterized, synthetically defined tool for dissecting cell adhesion and migration in vitro. Its receptor-specific, quantifiable effects enable mechanistic studies in cancer metastasis and neurodegeneration research. Ongoing work will clarify its role in complex ECM signaling networks and its potential as a competitive inhibitor in translational models. For purchase or further technical details, refer to the Laminin (925-933) product page at APExBIO.